KalVista Pharmaceuticals (KALV) Operating Income Growth (3y) (2019 - 2025)
KalVista Pharmaceuticals (KALV) Operating Income Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -30.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -30.89% |
| Apr 30, 2025 | -27.09% |
| Oct 31, 2024 | -24.74% |
| Jul 31, 2024 | -31.34% |
| Apr 30, 2024 | -39.00% |
| Jan 31, 2024 | -37.84% |
| Oct 31, 2023 | -32.52% |
| Jul 31, 2023 | -26.29% |
| Apr 30, 2023 | -52.44% |
| Jan 31, 2023 | -28.42% |
| Oct 31, 2022 | -40.72% |
| Jul 31, 2022 | -40.13% |
| Apr 30, 2022 | -33.53% |
| Jan 31, 2022 | -58.83% |
| Oct 31, 2021 | -68.97% |
| Jul 31, 2021 | -40.68% |
| Apr 30, 2021 | -82.48% |
| Jan 31, 2021 | -42.81% |
| Oct 31, 2020 | -29.12% |
| Jul 31, 2020 | -38.36% |